Klichinsky Michael 4
4 · Carisma Therapeutics Inc. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
Klichinsky Michael
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-10-01$0.26/sh−165,000$42,405→ 319,347 total - Sale
Common Stock
2025-10-03$0.26/sh−119,347$31,078→ 0 total - Sale
Common Stock
2025-10-02$0.25/sh−200,000$50,860→ 119,347 total
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2504 to $0.2721, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2501 to $0.2616, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2588 to $0.2670, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.